scholarly article | Q13442814 |
P50 | author | Luigi Naldini | Q16574299 |
Elia Stupka | Q30089912 | ||
Davide Cittaro | Q38804020 | ||
Bernhard Gentner | Q39508211 | ||
Anna Kajaste-Rudnitski | Q43802321 | ||
P2093 | author name string | Dejan Lazarevic | |
Michela Riba | |||
Ivan Cuccovillo | |||
Sara Bartolaccini | |||
Francesco Piras | |||
Carolina Petrillo | |||
P2860 | cites work | ATM activation by DNA double-strand breaks through the Mre11-Rad50-Nbs1 complex | Q24298863 |
DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response | Q24317784 | ||
Functional interaction of H2AX, NBS1, and p53 in ATM-dependent DNA damage responses and tumor suppression | Q24557573 | ||
Primitive hematopoietic cells resist HIV-1 infection via p21 | Q24681819 | ||
Advances in umbilical cord blood manipulation-from niche to bedside | Q26824305 | ||
Inflammatory modulation of HSCs: viewing the HSC as a foundation for the immune response | Q27003372 | ||
HIV-1 evades innate immune recognition through specific cofactor recruitment | Q27680544 | ||
Linear models and empirical bayes methods for assessing differential expression in microarray experiments | Q27860758 | ||
Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration | Q28242708 | ||
Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective | Q28388806 | ||
Genomic HIV RNA induces innate immune responses through RIG-I-dependent sensing of secondary-structured RNA | Q28740542 | ||
Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery | Q29014419 | ||
p53 regulates hematopoietic stem cell quiescence. | Q33732098 | ||
p53-mediated hematopoietic stem and progenitor cell competition. | Q33857597 | ||
Interactions between HIV-1 and the cell-autonomous innate immune system. | Q33895123 | ||
Hematopoietic stem cell quiescence promotes error-prone DNA repair and mutagenesis | Q34076936 | ||
Quiescent haematopoietic stem cells are activated by IFN-gamma in response to chronic infection | Q34112414 | ||
HIV-1 causes CD4 cell death through DNA-dependent protein kinase during viral integration. | Q34348888 | ||
Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy | Q34356914 | ||
Cyclic GMP-AMP synthase is an innate immune sensor of HIV and other retroviruses | Q34362864 | ||
DNA-damage-induced type I interferon promotes senescence and inhibits stem cell function | Q34474083 | ||
HIV-1-derived lentiviral vectors directly activate plasmacytoid dendritic cells, which in turn induce the maturation of myeloid dendritic cells. | Q34623234 | ||
Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool | Q34668270 | ||
Activation of DNA damage response signaling by condensed chromatin | Q34713712 | ||
Trex1 exonuclease degrades ssDNA to prevent chronic checkpoint activation and autoimmune disease | Q34719398 | ||
Intracellular transport of recombinant adeno-associated virus vectors | Q35734826 | ||
HIV DNA integration | Q36065855 | ||
Genome-wide analysis of retroviral DNA integration | Q36263002 | ||
Attenuation of miR-126 activity expands HSC in vivo without exhaustion. | Q36455274 | ||
Homology-driven genome editing in hematopoietic stem and progenitor cells using ZFN mRNA and AAV6 donors. | Q36828138 | ||
In Vivo Tracking of Human Hematopoiesis Reveals Patterns of Clonal Dynamics during Early and Steady-State Reconstitution Phases | Q37089345 | ||
M-CSF improves protection against bacterial and fungal infections after hematopoietic stem/progenitor cell transplantation | Q37346652 | ||
MAPK signaling pathways in the regulation of hematopoiesis | Q37508518 | ||
No impact of lentiviral transduction on hematopoietic stem/progenitor cell telomere length or gene expression in the rhesus macaque model. | Q37690474 | ||
Hematopoiesis: a human perspective | Q37981372 | ||
Cellular innate immunity and restriction of viral infection: implications for lentiviral gene therapy in human hematopoietic cells | Q38390745 | ||
Gene therapy returns to centre stage | Q38607706 | ||
HIV replication: a game of hide and sense. | Q38656226 | ||
DNA damage primes the type I interferon system via the cytosolic DNA sensor STING to promote anti-microbial innate immunity | Q38908391 | ||
Risk stratification for invasive fungal infections in patients with hematological malignancies: SEIFEM recommendations. | Q38967328 | ||
Novel strategies for improving hematopoietic reconstruction after allogeneic hematopoietic stem cell transplantation or intensive chemotherapy | Q39031745 | ||
Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy: an ad-hoc analysis of a non-randomised, open-label, phase 1/2 trial. | Q39691004 | ||
Distinct routes of lineage development reshape the human blood hierarchy across ontogeny | Q39745504 | ||
The TLR1/2 agonist PAM(3)CSK(4) instructs commitment of human hematopoietic stem cells to a myeloid cell fate | Q39819090 | ||
Efficient Ex Vivo Engineering and Expansion of Highly Purified Human Hematopoietic Stem and Progenitor Cell Populations for Gene Therapy | Q40279626 | ||
Molecular linkage between the kinase ATM and NF-kappaB signaling in response to genotoxic stimuli | Q40312088 | ||
Coordinate dual-gene transgenesis by lentiviral vectors carrying synthetic bidirectional promoters. | Q40477022 | ||
CRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cells | Q40486239 | ||
CpG-ODN 2006 and human parvovirus B19 genome consensus sequences selectively inhibit growth and development of erythroid progenitor cells | Q40907249 | ||
Exit from dormancy provokes DNA-damage-induced attrition in haematopoietic stem cells. | Q41468517 | ||
Cyclosporin a and rapamycin relieve distinct lentiviral restriction blocks in hematopoietic stem and progenitor cells | Q41721059 | ||
Single-stranded DNA orchestrates an ATM-to-ATR switch at DNA breaks | Q42021074 | ||
A TLR and non-TLR mediated innate response to lentiviruses restricts hepatocyte entry and can be ameliorated by pharmacological blockade | Q42119020 | ||
ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays | Q43536416 | ||
IFNalpha activates dormant haematopoietic stem cells in vivo. | Q44358922 | ||
Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences | Q44491759 | ||
A synthetic double-stranded RNA, poly I:C, induces a rapid apoptosis of human CD34(+) cells | Q44523378 | ||
miRNA-126 Orchestrates an Oncogenic Program in B Cell Precursor Acute Lymphoblastic Leukemia | Q45855195 | ||
Silencing p21(Waf1/Cip1/Sdi1) expression increases gene transduction efficiency in primitive human hematopoietic cells | Q45883358 | ||
Hematopoietic stem cells reversibly switch from dormancy to self-renewal during homeostasis and repair | Q46210604 | ||
Suppression of HIV-1 infection by a small molecule inhibitor of the ATM kinase | Q46440743 | ||
A distinctive DNA damage response in human hematopoietic stem cells reveals an apoptosis-independent role for p53 in self-renewal. | Q51904571 | ||
Signaling through toll-like receptor 7/8 induces the differentiation of human bone marrow CD34+ progenitor cells along the myeloid lineage. | Q54575672 | ||
HIV-1 genome nuclear import is mediated by a central DNA flap | Q73726795 | ||
Stem Cells and DNA Damage: Persist or Perish? | Q84691536 | ||
P4510 | describes a project that uses | Cytoscape | Q3699942 |
P433 | issue | 9 | |
P304 | page(s) | 1198-1211 | |
P577 | publication date | 2017-09-01 | |
P1433 | published in | EMBO Molecular Medicine | Q15817279 |
P1476 | title | Lentiviral vectors escape innate sensing but trigger p53 in human hematopoietic stem and progenitor cells | |
P478 | volume | 9 |
Q97529378 | Antiviral immunity and nucleic acid sensing in haematopoietic stem cell gene engineering |
Q91632497 | Assessing the Impact of Cyclosporin A on Lentiviral Transduction and Preservation of Human Hematopoietic Stem Cells in Clinically Relevant Ex Vivo Gene Therapy Settings |
Q95329207 | Cas9 activates the p53 pathway and selects for p53-inactivating mutations |
Q60306229 | Cyclosporine H Overcomes Innate Immune Restrictions to Improve Lentiviral Transduction and Gene Editing In Human Hematopoietic Stem Cells |
Q92239257 | Episomal vectors based on S/MAR and the β-globin Replicator, encoding a synthetic transcriptional activator, mediate efficient γ-globin activation in haematopoietic cells |
Q64109055 | Gene Therapy Approaches to Functional Cure and Protection of Hematopoietic Potential in HIV Infection |
Q92283987 | Gene therapy targeting haematopoietic stem cells for inherited diseases: progress and challenges |
Q64240820 | Genetic engineering of hematopoiesis: current stage of clinical translation and future perspectives |
Q64075661 | Precise Gene Editing Preserves Hematopoietic Stem Cell Function following Transient p53-Mediated DNA Damage Response |
Q64973383 | Staurosporine Increases Lentiviral Vector Transduction Efficiency of Human Hematopoietic Stem and Progenitor Cells. |
Q89625766 | Successfully transfected primary peripherally mobilized human CD34+ hematopoietic stem and progenitor cells (HSPCs) demonstrate increased susceptibility to retroviral infection |
Q59443482 | Wake-up Sleepy Gene: Reactivating Fetal Globin for β-Hemoglobinopathies |
Search more.